Herbert Irving Comprehensive Cancer Center
Investigator
Ran Reshef, MD

212-342-0530

rr3036@cumc.columbia.edu
Dr. Reshef trained in Hematology, Oncology and Bone Marrow Transplantation and received a Master of Science degree in Translational Research from the University of Pennsylvania. He joined Columbia University in 2015 as Director of Translational Research for the Blood and Marrow Transplantation program. He is the Clinical Lead for the CAR-T Cell Program (link is external) at Columbia, a principal investigator at the Columbia Center for Translational Immunology and a member of the Herbert Irving Comprehensive Cancer Center.
Dr. Reshef serves as Director of Translational Research for the Blood and Marrow Transplantation program and Clinical Lead for the CAR-T Cell Program. He joined Columbia University in 2015 after spending 8 years at the University of Pennsylvania where he conducted research in stem-cell transplantation and immunotherapy. Dr. Reshef primarily cares for patients with leukemia, MDS, lymphoma, myeloma and other blood cancers and he oversees the clinical trials offered to patients undergoing stem-cell transplantation. His research focuses on innovative ways to improve the outcome of patients undergoing stem-cell transplants and novel cell therapies. Dr. Reshef's research is funded by the National Cancer Institute, American Society of Clinical Oncology, National Marrow Donor Program and Department of Defense. He previously received awards from the Leukemia & Lymphoma Society and American Society of Hematology.